New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aurora Cannabis Inc.
ACB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

242M

Drug Manufacturers - Specialty & Generic

4.41USD

Shape0.11 ( 2.56%)
Market Closed (as of Mar 14, 20:00 EDT)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-83%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated March 15, 2025
1W -0.23 % 1M -26.99 % 3M 2.80 % 1Y 19.19 %

Key Metrics

Shape
  • Market Cap

    242.04M


  • Shares Outstanding

    54.88M


  • Share in Float

    54.67M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    4.41


  • Average Volume

    2.84M


  • Beta

    2.487


  • Range

    3.31-9.35


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.auroramj.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ACB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$205M

Shape205%

2024-Revenue

$1.50

Shape-306%

2024-EPS

$125M

Shape-864%

2024-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Canaccord Genuity

upgrade

Previous: Hold

2024-02-16

Now: Positive

Canaccord Genuity

downgrade

Previous: Not converted

2022-09-21

Now: Hold

Maxim Group

downgrade

Previous: Not converted

2022-09-21

Now: Hold

Needham

initialise

Previous: Not converted

2022-09-21

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.80
vs -2.10

Q3.22

arrow
arrow

N/A

-0.80
vs -0.90

Q4.22

arrow
arrow

N/A

-1.40
vs -4.20

Q1.23

arrow
arrow

N/A

-1.50
vs -10.40

Q2.23

arrow
arrow

N/A

-0.40
vs -0.80

Q3.23

arrow
arrow

N/A

-0.50
vs -0.80

Q4.23

arrow
arrow

N/A

-0.20
vs -1.40

Q1.24

arrow
arrow

+107%

0.11
vs -1.50

Q2.24

arrow
arrow

N/A

-0.17
vs -0.40

Q3.24

arrow
arrow

N/A

-0.11
vs -0.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-8%

50.2M  vs 54.6M

Q3.22

arrow
arrow

-18%

49.3M  vs 60.1M

Q4.22

arrow
arrow

+2%

61.7M  vs 60.6M

Q1.23

arrow
arrow

+43%

72.1M  vs 50.4M

Q2.23

arrow
arrow

NA

50.2M  vs 50.2M

Q3.23

arrow
arrow

+29%

63.4M  vs 49.3M

Q4.23

arrow
arrow

+4%

64.4M  vs 61.7M

Q1.24

arrow
arrow

-7%

67.4M  vs 72.1M

Q2.24

arrow
arrow

+13%

56.7M  vs 50.2M

Q3.24

arrow
arrow

-19%

51.6M  vs 63.4M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-93%

-0.93
vs -0.93

Q3.22

arrow
arrow

-9%

-0.09
vs -0.93

Q4.22

arrow
arrow

-12%

-0.12
vs -0.09

Q1.23

arrow
arrow

+97%

0.97
vs -0.12

Q2.23

arrow
arrow

-93%

-0.93
vs 0.97

Q3.23

arrow
arrow

0%

-0.00
vs -0.93

Q4.23

arrow
arrow

-5%

-0.05
vs -0.00

Q1.24

arrow
arrow

-3%

-0.03
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

216

216
vs 233

-7%

Q2.23

arrow
arrow

201

201
vs 216

-7%

Q3.23

arrow
arrow

209

209
vs 201

4%

Q4.23

arrow
arrow

207

207
vs 209

-1%

Q1.24

arrow
arrow

179

179
vs 207

-14%

Q2.24

arrow
arrow

178

178
vs 179

-1%

Q3.24

arrow
arrow

155

155
vs 178

-13%

Q4.24

arrow
arrow

172

172
vs 155

11%

Earnings Growth

Latest News